And my special guest is willing to give you $10 in Bitcoin (BTC) if you take it seriously. Right now is a very important time to pay attention to what we are doing and what is happening. If you wait... it will be too late. This week we are holding several workshops and if you attend and pay attention my special guest is going to send you $10 in Bitcoin.

MIST Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 10.40%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $0.00

Milestone Pharmaceuticals Insider Trading History Chart

Milestone Pharmaceuticals Share Price & Price History

^$1.55

▼ -0.04 (-2.52%)

As of 04/26/2024 01:00 AM ET

Days: 30 | 90 | 365

Did You Get Your Free Bitcoin Yet?

From Crypto Swap Profits | Ad

>> Register right here

Milestone Pharmaceuticals Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
12/5/2022	David Bharucha	Insider	Buy	7,000	$4.69	$32,830.00	10,000
12/1/2022	David Bharucha	Insider	Buy	3,000	$4.86	$14,580.00	3,000
10/21/2022	Debra K Liebert	Director	Buy	4,000	$5.26	$21,040.00	4,000
10/19/2022	Robert James Wills	Director	Buy	15,000	$4.93	$73,950.00	15,000
9/7/2022	Rtw Investments, Lp	Major Shareholder	Buy	1,557,346	$8.71	$13,564,483.66	4,315,102
5/31/2022	Paul F Truex	Director	Buy	5,000	$5.60	$28,000.00	81,780

Forget AI, Imperium Is Expected to Grow 320,00% in 3 Years

From Banyan Hill Publishing | Ad

If you think AI is big, then you have got to check out something I call Imperium… By my calculations, it’s set to grow 320,000% in three years. (You can see my calculations here.)

Watch my video for all of the details

SEC Filings (Institutional Ownership Changes) for Milestone Pharmaceuticals (NASDAQ:MIST)

86.18% of Milestone Pharmaceuticals stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Milestone Pharmaceuticals Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
4/26/2024	Clear Creek Financial Management LLC	25,000	$45K	0.0%	-21.3%	0.047%
4/23/2024	BML Capital Management LLC	606,145	$1.09M	0.7%	+37.0%	1.140%
1/30/2024	BML Capital Management LLC	442,352	$0.74M	0.6%	+62.3%	1.321%
9/21/2023	Barclays PLC	800,776	$2.28M	0.0%	-5.4%	2.399%
8/21/2023	Affinity Asset Advisors LLC	300,068	$0.86M	0.3%	+50.5%	0.899%
8/11/2023	Beta Wealth Group Inc.	14,127	$40K	0.0%	N/A	0.042%
8/3/2023	Barclays PLC	800,776	$2.28M	0.0%	-5.4%	2.400%
7/27/2023	Virtu Financial LLC	11,743	$33K	0.0%	N/A	0.035%
7/24/2023	BML Capital Management LLC	272,500	$0.78M	0.7%	+23.9%	0.817%
7/17/2023	Clear Creek Financial Management LLC	31,929	$91K	0.0%	-11.1%	0.096%
7/14/2023	Valeo Financial Advisors LLC	118,699	$0.34M	0.0%	+4.4%	0.356%
5/16/2023	Alta Fundamental Advisers LLC	897,961	$3.54M	1.5%	+58.8%	2.698%
5/15/2023	Affinity Asset Advisors LLC	199,382	$0.79M	0.3%	+99.4%	0.599%
5/15/2023	RTW Investments LP	3,256,102	$12.83M	0.3%	-24.5%	9.782%
5/4/2023	Barclays PLC	846,828	$3.34M	0.0%	+32.0%	2.544%
4/20/2023	Clear Creek Financial Management LLC	35,929	$0.14M	0.0%	N/A	0.108%
4/14/2023	BML Capital Management LLC	220,000	$0.87M	0.7%	+22.2%	0.661%
2/15/2023	Braidwell LP	1,164,849	$4.61M	0.2%	N/A	3.397%
2/14/2023	VR Adviser LLC	2,208,812	$8.75M	1.4%	-8.9%	6.442%
2/14/2023	Pura Vida Investments LLC	371,788	$1.47M	0.1%	-37.7%	1.084%
2/13/2023	BML Capital Management LLC	180,000	$0.71M	0.7%	N/A	0.525%
2/13/2023	Beta Wealth Group Inc.	14,127	$56K	0.0%	N/A	0.041%
2/9/2023	Valeo Financial Advisors LLC	113,699	$0.45M	0.0%	+50.6%	0.332%
2/1/2023	Bank of Montreal Can	152,636	$0.61M	0.0%	+217.3%	0.445%
11/15/2022	Pura Vida Investments LLC	596,531	$5.48M	0.3%	-39.6%	1.740%
11/15/2022	Boxer Capital LLC	698,861	$6.42M	0.4%	-68.8%	2.038%
11/14/2022	LMR Partners LLP	38,495	$0.35M	0.0%	+228.1%	0.128%
11/14/2022	VR Adviser LLC	2,425,737	$22.29M	3.3%	N/A	8.083%
11/3/2022	Barclays PLC	540,582	$4.97M	0.0%	+155.3%	1.801%
10/31/2022	Valeo Financial Advisors LLC	75,500	$0.69M	0.0%	N/A	0.252%
10/13/2022	National Bank of Canada FI	2,880	$26K	0.0%	-80.6%	0.010%
8/15/2022	Acuta Capital Partners LLC	457,200	$2.81M	1.6%	+20.3%	1.528%
2/14/2022	Boxer Capital LLC	2,238,861	$14.67M	0.6%	-13.0%	7.501%
2/14/2022	Eversept Partners LP	147,165	$0.96M	0.1%	+29.6%	0.493%
2/10/2022	Bleichroeder LP	250,000	$1.64M	0.3%	N/A	0.838%
2/10/2022	Acadian Asset Management LLC	12,381	$79K	0.0%	+63.0%	0.041%
1/24/2022	National Bank of Canada FI	14,742	$96K	0.0%	N/A	0.049%
11/16/2021	Millennium Management LLC	695,241	$3.97M	0.0%	-3.3%	2.329%
11/15/2021	Pura Vida Investments LLC	850,312	$4.86M	0.1%	+21.0%	2.849%
11/15/2021	Eversept Partners LP	113,597	$0.65M	0.0%	N/A	0.381%
11/9/2021	Barclays PLC	200,688	$1.15M	0.0%	-1.6%	0.672%
8/18/2021	Ikarian Capital LLC	1,980,400	$10.89M	0.9%	+7.8%	6.635%
8/17/2021	Boothbay Fund Management LLC	224,758	$1.24M	0.0%	+7.9%	0.753%
8/16/2021	Morgan Stanley	885,199	$4.87M	0.0%	+4.0%	2.966%
8/13/2021	Renaissance Technologies LLC	107,554	$0.59M	0.0%	-50.3%	0.360%
8/12/2021	Dimensional Fund Advisors LP	47,200	$0.26M	0.0%	+23.2%	0.158%
8/11/2021	Susquehanna Fundamental Investments LLC	51,502	$0.28M	0.0%	-15.1%	0.173%
5/18/2021	Millennium Management LLC	717,797	$4.16M	0.0%	-2.4%	2.405%
5/18/2021	RA Capital Management L.P.	2,246,503	$13.01M	0.2%	-3.5%	7.527%
5/18/2021	Morgan Stanley	851,042	$4.93M	0.0%	-13.0%	2.851%
5/18/2021	Orbimed Advisors LLC	2,583,821	$14.96M	0.1%	+3.6%	8.657%
5/18/2021	Boxer Capital LLC	2,572,194	$14.89M	0.5%	+3.8%	8.618%
5/17/2021	Price T Rowe Associates Inc. MD	267,997	$1.55M	0.0%	-28.5%	0.898%
5/17/2021	Goldman Sachs Group Inc.	12,004	$70K	0.0%	-46.0%	0.040%
5/14/2021	Dimensional Fund Advisors LP	38,316	$0.22M	0.0%	+71.4%	0.128%
5/14/2021	TD Asset Management Inc.	18,704	$0.11M	0.0%	-18.9%	0.063%
5/13/2021	Barclays PLC	156,876	$0.91M	0.0%	+320.4%	0.526%
5/13/2021	Renaissance Technologies LLC	216,400	$1.25M	0.0%	+32.0%	0.725%
5/12/2021	Geode Capital Management LLC	20,859	$0.12M	0.0%	+10.1%	0.070%
5/12/2021	Pura Vida Investments LLC	467,640	$2.71M	0.1%	+3.9%	1.567%
3/26/2021	Susquehanna International Group LLP	10,144	$68K	0.0%	N/A	0.034%
3/8/2021	Dimensional Fund Advisors LP	22,355	$0.15M	0.0%	N/A	0.075%
2/25/2021	Dimensional Fund Advisors LP	22,355	$0.15M	0.0%	N/A	0.075%
2/16/2021	Orbimed Advisors LLC	2,493,109	$16.70M	0.1%	+546.2%	8.360%
2/16/2021	Squarepoint Ops LLC	23,633	$0.16M	0.0%	N/A	0.079%
2/16/2021	Morgan Stanley	977,741	$6.55M	0.0%	+34.4%	3.278%
2/16/2021	Pura Vida Investments LLC	450,000	$3.02M	0.1%	+350.0%	1.509%
2/16/2021	Price T Rowe Associates Inc. MD	374,957	$2.51M	0.0%	-35.0%	1.257%
2/12/2021	Ikarian Capital LLC	1,836,545	$12.31M	0.5%	+5.3%	6.158%
2/10/2021	Renaissance Technologies LLC	164,000	$1.10M	0.0%	+986.1%	0.550%
11/17/2020	Boxer Capital LLC	1,777,194	$13.01M	0.4%	+61.2%	7.192%
11/16/2020	Boothbay Fund Management LLC	198,708	$1.46M	0.1%	+315.7%	0.804%
11/13/2020	Morgan Stanley	727,239	$5.32M	0.0%	+21.5%	2.943%
11/10/2020	State Street Corp	17,562	$0.13M	0.0%	N/A	0.071%
11/5/2020	California Public Employees Retirement System	51,200	$0.38M	0.0%	+61.0%	0.207%
9/15/2020	Two Sigma Advisers LP	20,900	$79K	0.0%	N/A	0.085%
9/15/2020	Schonfeld Strategic Advisors LLC	33,200	$0.13M	0.0%	N/A	0.134%
8/13/2020	K2 Principal Fund L.P.	169,730	$0.64M	0.1%	N/A	0.689%
8/12/2020	California Public Employees Retirement System	31,800	$0.12M	0.0%	N/A	0.129%
5/15/2020	Ghost Tree Capital LLC	208,733	$0.38M	0.1%	-11.2%	0.850%
5/14/2020	Tekla Capital Management LLC	213,310	$0.39M	0.0%	-71.4%	0.869%
5/14/2020	Sphera Funds Management LTD.	67,992	$0.13M	0.0%	N/A	0.277%
5/1/2020	UBS Group AG	13,499	$25K	0.0%	N/A	0.055%

Data available starting January 2016

Milestone Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of cardiovascular medicines. The company's lead product candidate is etripamil, a novel and potent calcium channel blocker, which is in Phase III clinical trial for the treatment of paroxysmal supraventricular tachycardia in the United States and Canada; and Phase II clinical trial for the treatment of atrial fibrillation and rapid ventricular rate. It has a license and collaboration agreement with Ji Xing Pharmaceuticals to develop and commercialize etripamil prophylactic and therapeutic uses in humans, as well as with the Montreal Heart Institute, the WCN network, and other research centers. The company was incorporated in 2003 and is headquartered in Montréal, Canada.

Today's Range

Now: $1.55

$1.53

$1.64

50 Day Range

MA: $1.67

$1.42

$2.20

52 Week Range

Now: $1.55

$1.33

$4.49

Volume

469,718 shs

Average Volume

309,905 shs

Market Capitalization

$82.12 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.77

Who are the company insiders with the largest holdings of Milestone Pharmaceuticals?: Milestone Pharmaceuticals' top insider shareholders include:
Rtw Investments, Lp (Major Shareholder)
Paul F Truex (Director)
Robert James Wills (Director)
David Bharucha (Insider)
Debra K Liebert (Director)
Learn More about top insider investors at Milestone Pharmaceuticals.
Who are the major institutional investors of Milestone Pharmaceuticals?: Milestone Pharmaceuticals' top institutional investors include:
BML Capital Management LLC — 1.14%
Clear Creek Financial Management LLC — 0.05%
Learn More about top institutional investors of Milestone Pharmaceuticals stock.
Which major investors are selling Milestone Pharmaceuticals stock?: During the last quarter, MIST stock was sold by these institutional investors:
Clear Creek Financial Management LLC
Which major investors are buying Milestone Pharmaceuticals stock?: During the last quarter, MIST stock was purchased by institutional investors including:
BML Capital Management LLC
Within the previous year, these company insiders have bought Milestone Pharmaceuticals stock:
Rtw Investments, Lp (Major Shareholder)
Paul F Truex (Director)
Robert James Wills (Director)
David Bharucha (Insider)
Debra K Liebert (Director)
Learn More investors buying Milestone Pharmaceuticals stock.